Ultragenyx Pharmaceutical Inc.

Go to Ultragenyx Pharmaceutical Inc. Website

$29.48

1.02 (3.58%)
Live
Previous Close

$28.46

Day Range

$27.65 - $29.15

Previous Day Range

$27.88 - $28.8

Market Cap

$2.7 billion USD

Day Vol.

1.7 million

Previous Day Vol.

1.7 million

Currency

USD

Primary Exchange

Nasdaq

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic dise...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Pomerantz Law Firm is investigating potential securities fraud by Mereo BioPharma Group and its development partner Ultragenyx Pharmaceutical following a stock price drop after a clinical trial update.

Related tickers: MREO, RARE.

Read Full Article

Pomerantz Law Firm is investigating potential securities fraud by Ultragenyx Pharmaceutical and Mereo BioPharma following a stock price drop after announcing a delayed final analysis of a Phase 3 clinical study.

Related tickers: RARE, MREO.

Read Full Article
Trending Tickers

Please sign in to view